Summary
B & V PHARMA is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €939,237 and a net result of €213,775. Equity is growing by about 4.1% per year across the filed financial years. Its solvency ranks better than 44% of 6,673 sector peers (NACE 64, financial year 2025). The company has been active since 2005 and the Belgian Official Gazette contains no insolvency or warning signals.
Articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “Het verlenen van advies in verband met beheer en management van ondernemingen; Het beheer van apotheken; Het beheer van patrimonium; Het…” (deed in Dutch)
5 activities (deed in Dutch)
- Het verlenen van advies in verband met beheer en management van ondernemingen;
- Het beheer van apotheken;
- Het beheer van patrimonium;
- Het nemen van participaties in andere ondernemingen;
- Het beheer en de aan- en verkoop van onroerende goederen.
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- B & V PHARMA
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaamse Gewest, Artikel 2” (deed in Dutch)
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- Each director alone
- Board ruleHow the board is made up, meets and takes decisions.
- “Met of zonder beperking van duur, één of meer bestuurders” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- First Friday of June at 20:00
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Ontbinding op elk moment, Artikel 27” (deed in Dutch)
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Bij ontbinding om welke reden en op welk ogenblik ook, Artikel 28” (deed in Dutch)